MedTrace Logo

Heated Humidified High Flow Nasal Cannula for Children With Obstructive Sleep Apnea

NCT02515409 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2015-08-04

No results posted yet for this study

Summary

The purpose of this study is to determine whether heated humidified high flow nasal cannula (HHHFNC) is effective as a treatment of obstructive sleep apnea syndrome (OSAS) compared to continues positive airway pressure (CPAP) treatments in children and to compare their adherence and compliance.

Conditions

  • Sleep Apnea, Obstructive

Interventions

DEVICE

HHHFNC

After the treatment with CPAP fails, the participants will use HHHFNC as a treatment for OSAS.

DEVICE

CPAP

CPAP, as a first line treatment in OSAS.

Sponsors & Collaborators

  • Tel-Aviv Sourasky Medical Center

    lead OTHER_GOV

Principal Investigators

  • Keren Armoni-Domany, Dr. · Tel-Aviv Sourasky Medical Center

Eligibility

Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2017-08-31
Completion
2017-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02515409 on ClinicalTrials.gov